BioHarvest Sciences Inc. (NASDAQ: BHST) is now covered by analysts at Maxim Group. They set a "buy" rating and a $12.00 price target on the stock.
Could This Partnership Yield The Holy Grail Of Sweeteners? [Forbes]
Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology [Yahoo! Finance]
BioHarvest Sciences Inc. (NASDAQ: BHST) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $14.00 price target on the stock.
Diamond Equity Research Releases Update Note on BioHarvest Sciences Inc. (NASDAQ: BHST, CNSX: BHSC) [Yahoo! Finance]